Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Formulation, Ingredients, Dosage Forms, Drug Delivery, Standards & Regulation, Small Molecules

Staying On Trend

sponsored by Colorcon

If you want to create a patient-centric medicine with the best chances of compliance, then paying attention to the design of your tablet is crucial. But as well as keeping patients in mind, it’s also important to consider manufacturing – decisions made about a tablet and its formulation, including its coating finish, can have a significant impact on production efficiency (1, 2). In short, your formulation strategy matters for many different reasons.

Over the past two decades with Colorcon, I have seen a lot of change in terms of formulation needs as companies strive to be more efficient and deliver better medicines. Importantly, our customers’ requirements need solutions to match their business challenges and production needs, as well as the needs of patients. Colorcon is a unique company in that it is extremely innovative and agile, even though we operate within a tightly regulated market. This is important, as it means we can respond as market needs change, providing exceptional products, local technical support and regional production capabilities. Today, for example, many pharma companies have regional manufacturing facilities and require the same raw materials at the same consistency and quality for use across these different geographical territories. Through expansion of our global footprint, Colorcon now has capabilities in strategic locations around the world to enable easy, local access and supply for our customers. Our industry expertise has continued to deepen over the years. While Colorcon’s focus has always been in film coating and speciality excipients, through our alliance with DuPont we also represent an extensive line of excipients for modified release applications. This is important expertise that pharma companies are looking for in a long-term partner.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Ali Rajabi-Siabhoomi

Ali Rajabi-Siabhoomi is Vice President and Chief Scientific Officer at Colorcon.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register